Company Financials

Middle East Healthcare Company Financials

Saudi riyal

business Middle East Healthcare Company Company Profile

Main Stock Listing

Tadawul: 4009

Market Capitalization SR7.30 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 34.48
Forward PE 21.20
Price to Sales TTM SR2.56
Price to Book MRQ SR4.30
Enterprise to Revenue 3.43
Enterprise to EBITDA 15.91

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 7.41%
Operating Margin 15.83%
Return on Assets TTM 5.25%
Return on Equity TTM 12.80%

Income Statement

Revenue TTM SR2,853,751,552
Revenue per Share TTM SR31.01
Quarterly Revenue Growth 9.10%
Gross Profit TTM SR1,115,102,976
EBITDA SR673,838,788
Net Income to Common TTM SR211,360,336
Diluted EPS TTM SR2.30
Quarterly Earnings Growth YoY 15.80%

Balance Sheet

Total Cash MRQ SR49,864,184
Total Cash per Share MRQ SR0.54
Total Debt MRQ SR
Total Debt to Equity MRQ 142.25
Current Ratio MRQ 1.74
Book Value per Share MRQ SR18.46

Cash Flow

Operating Cash Flow TTM SR664,827,136
Levered Free Cash Flow TTM SR-88,799,864

4009 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 92,040,000
Float Shares 40,810,536
Avg 10 Volume 383,929
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 54.69%
% Held by Institutions 4.59%

Stock Price Summary

Beta 0.41
Fifty Two Week Low SR61.50
Fifty Two Week High SR134.40
Fifty Two Week Change -21.94%
Day 50 MA SR71.27
Day 200 MA SR76.90

Dividends and Splits

Forward Annual Dividend Rate SR8.00
Forward Annual Dividend Yield 10.09%
Trailing Annual Dividend Rate SR2.00
Trailing Annual Dividend Yield 2.52%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2018-06-25
Last Split Factor
Last Split Date